Biofrontera Inc. (BFRI)
NASDAQ: BFRI · IEX Real-Time Price · USD
0.840
-0.052 (-5.83%)
At close: Jul 2, 2024, 4:00 PM
0.882
+0.042 (5.00%)
After-hours: Jul 2, 2024, 7:55 PM EDT
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $4.28 million as of July 2, 2024. Its market cap has decreased by -66.60% in one year.
Market Cap
4.28M
Enterprise Value
4.10M
1-Year Change
-66.60%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $55.50M to $4.28M, a decrease of -92.30%. That is a compound annual growth rate of -61.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 4.50M | 7.14% |
| Dec 29, 2023 | 4.20M | -82.86% |
| Dec 30, 2022 | 24.50M | -78.36% |
| Dec 31, 2021 | 113.20M | 103.96% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hoth Therapeutics | 4.91M |
| Bright Minds Biosciences | 4.69M |
| ReShape Lifesciences | 4.67M |
| Adial Pharmaceuticals | 4.61M |
| Venus Concept | 4.57M |
| Enveric Biosciences | 4.52M |
| Sonoma Pharmaceuticals | 4.37M |
| MyMD Pharmaceuticals | 4.36M |